Refing Pharmatech has achieved commercial production&sales of products including:Dobutamine、Tadalafil,etc.Innovative process technology research projects include:Migraine preventive drug-Atogepant(MK-8031,AGN-241689), Anti-HIV Agents-Dolutegravir sodium, Antimicrobial drug——Clinafloxacin、Antofloxacin, Antineoplastic agents——Brigatinib、Mitoxantrone,etc.
(4,4-Dimethoxy-butyl)-dimethyl-amine